Literature DB >> 22304362

Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.

Masafumi Inoue1, Takashi Konno, Kazuki Tainaka, Eiji Nakata, Hiro-O Yoshida, Takashi Morii.   

Abstract

Hyperphosphorylated forms of tau protein are the main component of paired helical filaments (PHFs) of neurofibrillary tangles in the brain of Alzheimer's disease patients. To understand the effect of phosphorylation on the fibrillation of tau, we utilized tau-derived phosphorylated peptides. The V(306)QIVYK(311) sequence (PHF6) in the microtubule-binding domain is known to play a key role in the fibrillation of tau, and the short peptide corresponding to the PHF6 sequence forms amyloid-type fibrils similar to those generated by full-length tau. We focused on the amino acid residue located at the N-terminus of the PHF6 sequence, serine or lysine in the native isoform of tau, and synthesized the PHF6 derivative peptides with serine or lysine at the N-terminus of PHF6. Peptides phosphorylated at serine and/or tyrosine were synthesized to mimic the possible phosphorylation at these positions. The critical concentrations of the fibrillation of peptides were determined to quantitatively assess fibril stability. The peptide with the net charge of near zero tended to form stable fibrils. Interestingly, the peptide phosphorylated at the N-terminal serine residue exhibited remarkably low fibrillation propensity as compared to the peptide possessing the same net charge. Transmission electron microscopy measurements of the fibrils visualized the paired helical or straight fibers and segregated masses of the fibers or heterogeneous rodlike fibers depending on the phosphorylation status. Further analyses of the fibrils by the X-ray fiber diffraction method and Fourier transform infrared spectroscopic measurements indicated that all the peptides shared a common cross-β structure. In addition, the phosphoserine-containing peptides showed the characteristics of β-sandwiches that could interact with both faces of the β-sheet. On the basis of these observations, possible protofilament models with four β-sheets were constructed to consider the positional effects of the serine and/or tyrosine phosphorylations. The electrostatic intersheet interaction between phosphate groups and the amino group of lysine enhanced the lateral association between β-sheets to compensate for the excess charge. In addition to the previously postulated net charge of the peptide, the position of the charged residue plays a critical role in the amyloid fibrillation of tau.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22304362     DOI: 10.1021/bi201451z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties.

Authors:  Rakesh Mishra; Cody L Hoop; Ravindra Kodali; Bankanidhi Sahoo; Patrick C A van der Wel; Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-09-18       Impact factor: 5.469

2.  Phosphorylation of serine 305 in tau inhibits aggregation.

Authors:  Kevin H Strang; Zachary A Sorrentino; Cara J Riffe; Kimberly-Marie M Gorion; Niran Vijayaraghavan; Todd E Golde; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2018-11-10       Impact factor: 3.046

3.  An ATR-FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ.

Authors:  Jonas Schartner; Andreas Nabers; Brian Budde; Julia Lange; Nina Hoeck; Jens Wiltfang; Carsten Kötting; Klaus Gerwert
Journal:  ACS Med Chem Lett       Date:  2017-06-11       Impact factor: 4.345

Review 4.  Protein phosphorylation in neurodegeneration: friend or foe?

Authors:  Sandra Tenreiro; Katrin Eckermann; Tiago F Outeiro
Journal:  Front Mol Neurosci       Date:  2014-05-13       Impact factor: 5.639

5.  Inhibition of peptide aggregation by means of enzymatic phosphorylation.

Authors:  Kristin Folmert; Malgorzata Broncel; Hans V Berlepsch; Christopher Hans Ullrich; Mary-Ann Siegert; Beate Koksch
Journal:  Beilstein J Org Chem       Date:  2016-11-18       Impact factor: 2.883

6.  Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases.

Authors:  Onder Albayram; Peter Angeli; Elizabeth Bernstein; Sean Baxley; Ziang Gao; Kun Ping Lu; Xiao Zhen Zhou
Journal:  J Alzheimers Dis Parkinsonism       Date:  2018-06-29

7.  Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer's Disease.

Authors:  Jangampalli Adi Pradeepkiran; P Hemachandra Reddy
Journal:  Cells       Date:  2019-03-19       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.